Qmetrics Technologies
Generated 5/10/2026
Executive Summary
Qmetrics Technologies is a Boston-based medical imaging analytics company founded in 2016, specializing in extracting quantitative data from medical images using proprietary radiomics, AI, and 3D visualization software. The company primarily serves as a service provider for pharmaceutical, biotech, and medical device companies, enabling precise measurement of disease and treatment effects in clinical trials. Its technology aims to enhance the efficiency and accuracy of imaging biomarkers, reducing trial timelines and supporting diagnostic applications. By leveraging advanced machine learning algorithms, Qmetrics helps clients derive actionable insights from complex imaging data, positioning itself as a key enabler in the digital health and AI-driven diagnostics space.
Upcoming Catalysts (preview)
- Q3 2026Major pharmaceutical partnership for clinical trial imaging services65% success
- Q4 2026Series A funding round to scale product development70% success
- TBDFDA clearance of a diagnostic imaging product40% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)